Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2014 1
2015 2
2016 4
2017 2
2018 1
2019 3
2020 5
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: Djavanshir
Page 1
Signs and Artifacts in Amyloid PET.
Lundeen TF, Seibyl JP, Covington MF, Eshghi N, Kuo PH. Lundeen TF, et al. Radiographics. 2018 Nov-Dec;38(7):2123-2133. doi: 10.1148/rg.2018180160. Radiographics. 2018. PMID: 30422768 Review.
Characterization of integrin engagement during defined human embryonic stem cell culture.
Meng Y, Eshghi S, Li YJ, Schmidt R, Schaffer DV, Healy KE. Meng Y, et al. FASEB J. 2010 Apr;24(4):1056-65. doi: 10.1096/fj.08-126821. Epub 2009 Nov 20. FASEB J. 2010. PMID: 19933311 Free PMC article.
We propose that a specific integrin "fingerprint" is necessary for maintenance of hES cell self-renewal, and synthetic culture systems must capture this engagement profile for hES cells to remain undifferentiated.-Meng, Y., Eshghi, S., Li, Y. J., Schmidt, R., Schaffer, D. …
We propose that a specific integrin "fingerprint" is necessary for maintenance of hES cell self-renewal, and synthetic culture systems must …
Association of White Matter Lesions and Outcome After Endovascular Stroke Treatment.
Luijten SPR, Bos D, Compagne KCJ, Wolff L, Majoie CBLM, Roos YBWEM, van Zwam WH, van Oostenbrugge RJ, Dippel DWJ, van der Lugt A, van Es ACGM; MR CLEAN trial investigators. Luijten SPR, et al. Neurology. 2021 Jan 19;96(3):e333-e342. doi: 10.1212/WNL.0000000000010994. Epub 2020 Oct 12. Neurology. 2021. PMID: 33046611 Clinical Trial.
Thrombus Permeability Is Associated With Improved Functional Outcome and Recanalization in Patients With Ischemic Stroke.
Santos EM, Marquering HA, den Blanken MD, Berkhemer OA, Boers AM, Yoo AJ, Beenen LF, Treurniet KM, Wismans C, van Noort K, Lingsma HF, Dippel DW, van der Lugt A, van Zwam WH, Roos YB, van Oostenbrugge RJ, Niessen WJ, Majoie CB; MR CLEAN Investigators. Santos EM, et al. Stroke. 2016 Mar;47(3):732-41. doi: 10.1161/STROKEAHA.115.011187. Epub 2016 Feb 4. Stroke. 2016. PMID: 26846859 Clinical Trial.
Endovascular Treatment: The Role of Dominant Caliber M2 Segment Occlusion in Ischemic Stroke.
Compagne KCJ, van der Sluijs PM, van den Wijngaard IR, Roozenbeek B, Mulder MJHL, van Zwam WH, Emmer BJ, Majoie CBLM, Yoo AJ, Lycklama À Nijeholt GJ, Lingsma HF, Dippel DWJ, van der Lugt A, van Es ACGM; MR CLEAN Registry Investigators. Compagne KCJ, et al. Stroke. 2019 Feb;50(2):419-427. doi: 10.1161/STROKEAHA.118.023117. Epub 2019 Jan 21. Stroke. 2019. PMID: 31287757 Free PMC article. Clinical Trial.
Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.
van der Ende NAM, Roozenbeek B, Berkhemer OA, Koudstaal PJ, Boiten J, van Dijk EJ, Roos YBWEM, van Oostenbrugge RJ, Majoie CBLM, van Zwam W, Lingsma HF, van der Lugt A, Dippel DWJ; MR CLEAN Investigators. van der Ende NAM, et al. Stroke. 2022 Jan;53(1):61-69. doi: 10.1161/STROKEAHA.121.035301. Epub 2021 Oct 5. Stroke. 2022. PMID: 34607469 Free PMC article. Clinical Trial.
Blood Pressure During Endovascular Treatment Under Conscious Sedation or Local Anesthesia.
Samuels N, van de Graaf RA, van den Berg CAL, Nieboer D, Eralp I, Treurniet KM, Emmer BJ, Immink RV, Majoie CBLM, van Zwam WH, Bokkers RPH, Uyttenboogaart M, van Hasselt BAAM, Mühling J, Burke JF, Roozenbeek B, van der Lugt A, Dippel DWJ, Lingsma HF, van Es ACGM; MR CLEAN Registry Investigators. Samuels N, et al. Neurology. 2021 Jan 12;96(2):e171-e181. doi: 10.1212/WNL.0000000000011006. Epub 2020 Oct 7. Neurology. 2021. PMID: 33028664 Free PMC article.
Stroke Etiology and Thrombus Computed Tomography Characteristics in Patients With Acute Ischemic Stroke: A MR CLEAN Registry Substudy.
Boodt N, Compagne KCJ, Dutra BG, Samuels N, Tolhuisen ML, Alves HCBR, Kappelhof M, Lycklama À Nijeholt GJ, Marquering HA, Majoie CBLM, Lingsma HF, Dippel DWJ, van der Lugt A; Coinvestigators MR CLEAN Registry. Boodt N, et al. Stroke. 2020 Jun;51(6):1727-1735. doi: 10.1161/STROKEAHA.119.027749. Epub 2020 May 14. Stroke. 2020. PMID: 32404040 Free article. Clinical Trial.
Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion.
Guglielmi V, LeCouffe NE, Zinkstok SM, Compagne KCJ, Eker R, Treurniet KM, Tolhuisen ML, van der Worp HB, Jansen IGH, van Oostenbrugge RJ, Marquering HA, Dippel DWJ, Emmer BJ, Majoie CBLM, Roos YBWEM, Coutinho JM; MR-CLEAN Registry Investigators. Guglielmi V, et al. Stroke. 2019 Dec;50(12):3360-3368. doi: 10.1161/STROKEAHA.119.026299. Epub 2019 Oct 29. Stroke. 2019. PMID: 31658903 Free PMC article.
20 results